BridgeBio Pharma Gross Profit Growth & History (BBIO)

BridgeBio Pharma's gross profit was $481.1M for fiscal 2025.

View full BridgeBio Pharma company overview

BridgeBio Pharma annual gross profit history

BridgeBio Pharma annual gross profit

Fiscal yearPeriod endedGross profitChangeGrowth
20252025-12-31$481.1M$263.1M+120.67%
20242024-12-31$218.0M$211.2M+3079.58%
20232023-12-31$6.9M−$67.4M−90.76%
20222022-12-31$74.2M$7.6M+11.43%
20212021-12-31$66.6M

BridgeBio Pharma gross profit trends

Between the periods ended 2021-12-31 and 2025-12-31, BridgeBio Pharma's gross profit increased from $66.6M to $481.1M, a change of $414.5M. The latest reported quarter, Q2 2026, shows $228.6M.

About the metric

What gross profit means

Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.

Calculation and source

SEC-reported and calculated gross profit

TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BridgeBio Pharma source filings ↗

Community posts

It’s quiet here.

No posts about BBIO yet. Start the conversation.

Write the first post